Table 1.
Gram-negative culture confirmed UTI occurrences by participant and total population in 12 month period immediate prior to study enrollment, in 23-month period post FimH antibody peak response and during the long-term follow-up period.
| UTI Occurrences and UTI Reduction Pre to Post Peak Ab Response | Participant 10-08-001 | Participant 10-08-002 | Participant 10-08-003 | Participant 10-09-001 | Total Population |
|---|---|---|---|---|---|
| Number of UTI occurrences pre study enrollment (12 month period) | 5 | 8 | 8 | 4 | 25 |
| Number of UTI occurrences post FimH peak Ab response Study Month 7-19 (12 month period) | 3 | 1 | 1 | 1 | 6 |
| Percent UTI Reduction | 40% | 88% | 88% | 75% | 75% |
| Number of UTI Occurrences in 5-year long-term Follow-up Period ( 50-58 months of follow-up) | 6 | 5 | 8 | 0 | 19 |